We are live on
!
Find out more
Puma Biotechnology
PBYI
PBYI
92 hedge funds and large institutions have $1.21B invested in Puma Biotechnology in 2013 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 35 increasing their positions, 32 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 9
20% more capital invested
Capital invested by funds: $1.01B → $1.21B (+$203M)
10% more funds holding
Funds holding: 84 → 92 (+8)
9% more repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 32
0.07% more ownership
Funds ownership: 79.12% → 79.19% (+0.07%)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
92
Holders Change
+8
Holders Change %
+9.52%
% of All Funds
2.98%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
18
Increased
35
Reduced
32
Closed
9
Calls
$307K
Puts
–
Net Calls
+$307K
Net Calls Change
+$307K
Top Buyers
| 1 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$78.8M |
| 2 |
Wells Fargo
San Francisco,
California
|
+$17.2M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$10.3M |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$8.72M |
| 5 |
SCM
Sigma Capital Management
Stamford,
Connecticut
|
+$5.66M |
Top Sellers
| 1 |
BCPEM
Bain Capital Public Equity Management
Boston,
Massachusetts
|
-$22.2M |
| 2 |
JP Morgan Chase
New York
|
-$14.6M |
| 3 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$14.2M |
| 4 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
-$13.6M |
| 5 |
O
OrbiMed
New York
|
-$13.1M |
